The investment marks the first time MY DR NOW has received external capital.

After a long and complex prenotification phase before the European Commission, Orrick obtained an early unconditional clearance of the transaction.

We advised Sosei Heptares, an international biopharmaceutical company and world-leader in G protein-coupled receptor (GPCR) focused structure-based ...

Medical Microinstruments is a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery.

Orrick advised German biopharmaceutical company MorphoSys on its equity participation transaction with biotech company Human Immunology Biosciences

The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.

Returning investor OMERS Growth Equity led the round, which also included Fidelity Management & Research Company and other current investors.

Under the definitive agreement, Kineta will become a wholly-owned subsidiary of Yumanity in an all-stock transaction.

Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.

Orrick advised Stripes on its investment in digital therapeutics company Hello Heart’s $70 million Series D funding round. 

Franklin Monsour posted this article on Law360 on taking more FCA cases to trial.

EU & US Privacy and Security Considerations for Covid-19 Data Processing Activities From Pandemic to Living with Covid written by Thora Johnson.

Our lawyers wrote Newsweek opinion piece calling for federal legislation to address privacy vulnerabilities after Dobbs.

Evolving Antitrust Scrutiny of Life Sciences M&A—What's in the Pipeline?

Partners from Orrick's Cyber, Privacy & Data Innovation Group partnered with the AHLA to explore the legal framework that helps to protect health ...

Here are five tips for building a robust patent portfolio that provides a solid intellectual property framework.

A Conversation on Leveraging Spinouts to Preserve and Create Value During Financing Rounds, M&A and IPO Planning

The U.S. DOJ Civil Division’s Consumer Protection Branch (CPB) first-ever “Recent Highlights” report leads with CPB’s work on consumer health and ...

A Conversation on the Future of Longevity, Cell Regeneration and Senescence

Six noteworthy trends that life sciences and healthcare companies should continue to keep an eye on in 2022.

Orrick's State Attorneys General team examines recent actions around the United States.

VC Investment Surges in European Life Science

We analyze new rules prohibiting information blocking rules for health tech companies and outline steps they can take to ensure compliance.

The U.S. Federal Trade Commission issued a policy statement providing clarity on the scope of its 2009 Health Breach Notification Rule.

Attacks on the life sciences and healthcare sectors increased significantly in the last year.

A Conversation on Spinouts – Unlocking Market Value and Creating Business Opportunities

Record-breaking Markets and a Candid Conversation on University Spinouts

We review full-year 2020 data in depth to identify and summarize the key trends that shaped venture investment across the sector.

We dig deeper into key underwriting topics for fintech, edtech and healthtech/medtech deals.

Congratulations to all of the members of the Orrick Life Sciences team recognized at this year’s LMG Life Sciences Awards.

In the first half of 2022, our teams advised on 80 mergers, acquisitions, VC financings and other transactions in the Life Sciences sector.

Congratulations to Orrick partner Gregg Griner on being recognized as a Go-To Lawyer for Healthcare and Life Sciences by Massachusetts Lawyers Weekly.

Welcome to Tony Chan who joins the firm as a partner focused on advising companies and investors in the life sciences and tech sectors.

Eileen Cole and Craig Falls join the firm as partners in our Antitrust and Competition practice.

Orrick welcomes Franklin Monsour, a former federal prosecutor and experienced white collar and regulatory adviser to the life sciences sector.

LMG recognizes the individuals and companies behind the most innovative and challenging life sciences work of the past year.

Orrick announced today that Thora Johnson has joined our Cyber, Privacy & Data Innovation practice as a partner in Washington, DC.